Procell Therapies

What Procell Therapies does

Procell Therapies is a privately held US-based company that sells a proprietary microchanneling aesthetic system to licensed practitioners and serves end consumers through a certified provider network. The core technology is a medical-grade microchanneling device that uses a linear stamping method to create uniformly distributed micro-channels in the skin, stimulating natural collagen and elastin production without penetrating living tissue and without the skin tearing associated with conventional microneedling. The system is paired with a proprietary MicroChannel Delivery Serum containing bio-engineered growth factors, cytokines, and DNA Repair Enzymes in a hyaluronic acid suspension, designed to replace cellular signaling proteins that decline with age.

Name

Procell Therapies

Legal name

Procell Therapies

Website

https://procelltherapies.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

Procell Therapies is a private US company that sells a proprietary microchanneling device and accompanying bio-engineered growth-factor serums to licensed practitioners, and connects consumers to certified providers for skin-rejuvenation treatments.

Ownership category

akta.pro rank

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Microchanneling Device Sales: Sale of microchanneling devices to licensed practitioners and aesthetic professionals for use in their practices.
2. Consumable Serums and Aftercare Products: Sale of Microchannel Delivery Serum and aftercare products that are required for the treatment system. The Procell Microchanneling system is designed to work as a whole, with serums providing the signaling proteins for collagen repair and building.
3. Treatment Services: Direct-to-consumer microchanneling treatment services provided through certified providers.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Procell Therapies manufactures and sells a proprietary microchanneling device and accompanying serum line to licensed aesthetic practitioners, while also making its serums and aftercare products available directly to consumers online. The company supports a network of certified providers offering in-office Procell microchanneling treatments and trains new practitioners through workshops.

Product overview

Procell Therapies offers a unified microchanneling system consisting of a proprietary microchanneling device and配套的MicroChannel Delivery Serum. The system is designed for licensed practitioners to perform minimally invasive skin treatments. The device creates micro-channels while the serum delivers growth factors, cytokines, and DNA Repair Enzymes to stimulate natural collagen production. The company also provides treatment services directly to consumers and offers workshops for practitioner training.

Differentiator

Problem solved

Functional benefit

Products and services

• Procell Microchanneling Device A proprietary microchanneling device using a linear stamping method, sold to licensed aesthetic practitioners for in-office skin rejuvenation treatments.
• MicroChannel Delivery Serum A topical serum applied during and after microchanneling treatments, formulated with bio-engineered growth factors, cytokines, and DNA Repair Enzymes.
• MicroChannel Aftercare Serum Aftercare topical serum available to consumers and practitioners for post-treatment skin support.
• Procell Microchanneling Treatment An in-office skin rejuvenation treatment performed by certified Procell providers using the Procell device and serums; consumers locate providers via the Get a Treatment directory.
• Procell Practitioner Workshops Training workshops for licensed practitioners on performing Procell microchanneling treatments, serving as the entry point into the Procell practitioner network.

Quantifiable outcome

• Results often visible within first 24 hours after treatment
• +3 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators2 records

Recent moves1 record

Expansion highlights4 records

Broad incumbents

• Alma Lasers: Alma (a Sisram Medical company) sells a broad portfolio of aesthetic and surgical energy-based devices, including microneedling and skin-resurfacing systems, to practitioners worldwide. Overlaps with Procell in minimally invasive skin rejuvenation for the same customer base.
• Cutera: Cutera is a publicly traded aesthetic device company offering laser and energy-based platforms (e.g., Secret RF, truSculpt) used by dermatologists and medspas. Comparable as a broader incumbent in the practitioner's office with overlapping skin-rejuvenation use cases.
• Sciton: Sciton sells aesthetic and laser platforms (e.g., Halo, BBL, mJOULE) to dermatologists and plastic surgeons with a practitioner-direct GTM. Comparable as an energy- and device-driven aesthetic incumbent serving the same practitioner and use-case universe as Procell.
• Cynosure (Hologic): Cynosure, now part of Hologic, markets aesthetic laser and energy-based workstations (including Potenza RF microneedling) to dermatologists and medspas. Comparable as a broad incumbent in the practitioner aesthetic device category.
• Solta Medical (Bausch Health): Solta Medical, owned by Bausch Health, sells skin-rejuvenation and body-contouring systems such as Fraxel and Clear + Brilliant to practitioners. Comparable as a broad aesthetic device incumbent overlapping with Procell's collagen-induction positioning.

Others

• SkinCeuticals (L'Oréal): SkinCeuticals, owned by L'Oréal, is a professional skincare brand sold through dermatologists, medspas, and licensed practitioners. Adjacent and enabling to Procell's ecosystem as a complementary post-procedure skincare brand sharing the same practitioner channel and end consumers.

Direct peers

• Crown Aesthetics (SkinPen): Crown Aesthetics markets SkinPen, the first FDA-cleared microneedling device, sold to licensed practitioners with proprietary protocols. Direct competitor to Procell's microchanneling device-plus-serum aesthetic system in the same practitioner channel and use cases.
• Dermapen World: Dermapen makes motorized microneedling pens widely used by aestheticians, dermatologists, and medspas. Competes head-to-head with Procell in the same practitioner-installed, minimally invasive skin rejuvenation category.
• InMode (Morpheus8): InMode's Morpheus8 combines microneedling with radiofrequency for skin remodeling and is sold to medspas and dermatologists via an enterprise sales motion. Directly competes with Procell in the device-driven, collagen-induction aesthetic procedure category.

Emerging players

• Beauty Health Company (HydraFacial): Beauty Health runs the HydraFacial device-plus-serum aesthetic system sold to spas and medspas with a strong DTC and practitioner brand. Comparable to Procell as a device-plus-consumable aesthetic platform targeting the same end-consumer outcomes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Instagraminstagram.com/microchanneling
• LinkedInlinkedin.com/company/procell-therapies

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Procell Therapies